This inventor holds 1 USPTO granted patent. Top assignee: Stemedica Cell Technologies, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Inventor M.G. Muralidhar – Innovating Therapeutic Stem Cell Technology
Introduction
M.G. Muralidhar is a notable inventor located in Poway, CA, who has made significant contributions in the field of biotechnology, particularly focusing on therapeutic stem cells. His innovative approach towards transgenic stem cells unveils new possibilities in medical treatments and regenerative medicine.
Latest Patents
M.G. Muralidhar holds one patent titled "Transgenic therapeutic stem cells and methods for their use and manufacture." This groundbreaking invention relates to transgenic stem cells designed for therapeutic applications. The stem cells developed under this invention incorporate at least one therapeutic transgene that is expressed when transplanted into a subject. Notably, the patent also discusses methods for utilizing and manufacturing these transgenic stem cells, including the potential use of transiently transgenic G-CSF bone marrow stem cells to treat ischemic conditions affecting central nervous system tissues.
Career Highlights
M.G. Muralidhar is associated with Stemedica Cell Technologies, Inc., a company dedicated to advancing cell therapies. His work at Stemedica highlights his commitment to developing innovative solutions that utilize stem cell technology to address critical health challenges.
Collaborations
M.G. Muralidhar collaborates with other talented professionals in the field, including Alex Kharazi and Grigory Vertelov. Together, they contribute their expertise to further research and development initiatives, enhancing the impact of the company's advancements in cell technology.
Conclusion
M.G. Muralidhar's inventive spirit and dedication to the field of biotechnology are evident through his patent on transgenic therapeutic stem cells. His work not only represents a significant advancement in medical technology but also offers hope for improved therapies in treating various illnesses. As his career progresses, it will be interesting to observe the further innovations he brings to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile